Literature DB >> 20960305

Prokaryotic expression and potential application of the truncated PCV-2 capsid protein.

Zhong-zi Lou1, Zhi-yong Li, Gang Wang, Jian-qiang Li, Xi Lan, Xue-rui Li, Xiang-ping Yin, Ji-xing Liu, Si-dang Liu.   

Abstract

Three pairs of specific primers were designed to amplify the F2-1, F2-2 and XF2-2 truncated sequences of ORF2 which encodes the capsid protein of porcine circovirus type 2 (PCV-2). The F2-1 sequence had most of the NLS region of ORF2, but the F2-2 and XF2-2 genes had the NLS region deleted. Truncated genes were subcloned into pET-32a(+) vectors to construct recombinant fusion expression vectors. The vectors were then transformed into Rosetta(DE3) E. coli and expressed by induction of IPTG. Expressed proteins were detected by western blotting and ELISA. The protein with best immunoreactivity was confirmed and selected, then utilized to inoculate SPF rabbits to prepare polyclonal antibodies. The protein and prepared polyclonal antibody were utilized to detect sera samples against PCV-2 from Shandong province and PCV-2 particles in PK-15 cells. In our study, three recombinant fusion proteins were successfully obtained, and the molecular weights of fusion proteins were 35.9 kDa, 33.6 kDa and 38.6 kDa respectively detected by SDS-PAGE. All of the proteins showed positive reaction with anti-PCV-2 antisera, and His-XF2-2 showed better immunoreactivity than the others. The protein of His-XF2-2 was coated as antigen in ELISA to detect the seroprevalence of PCV-2 in certain districts of Shandong province, the seropositivity rate was 27.7 % (73/264). Specific fluorescence and positive signals for PCV-2 could be detected in PK-15 cells inoculated with PCV-2 with the participation of prepared antibodies against His-XF2-2 in IFA and IPMA. Experimental results indicated that the truncated PCV-2 ORF2 gene containing most of the NLS region was successfully expressed in E. coli, and His-XF2-2 was demonstrated to have better immunoreactivity with anti-PCV-2 antisera than the other two fusion proteins. His-XF2-2 and prepared polyclonal antibodies against it had a satisfactory capability in detecting PCV-2 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960305      PMCID: PMC8227919          DOI: 10.1007/s12250-010-3111-7

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  21 in total

1.  Identification of a protein essential for replication of porcine circovirus.

Authors:  A Mankertz; J Mankertz; K Wolf; H J Buhk
Journal:  J Gen Virol       Date:  1998-02       Impact factor: 3.891

2.  Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes.

Authors:  D Mahé; P Blanchard; C Truong; C Arnauld; P Le Cann; R Cariolet; F Madec; E Albina; A Jestin
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

Review 3.  A review of porcine circovirus 2-associated syndromes and diseases.

Authors:  C Chae
Journal:  Vet J       Date:  2005-05       Impact factor: 2.688

4.  Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein.

Authors:  Porntippa Nawagitgul; Igor Morozov; Steven R Bolin; Perry A Harms; Steven D Sorden; Prem S Paul
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

5.  Identification of porcine circovirus in tissues of pigs with porcine dermatitis and nephropathy syndrome.

Authors:  C Rosell; J Segalés; J A Ramos-Vara; J M Folch; G M Rodríguez-Arrioja; C O Duran; M Balasch; J Plana-Durán; M Domingo
Journal:  Vet Rec       Date:  2000-01-08       Impact factor: 2.695

6.  Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells.

Authors:  Maria Trundova; Vladimir Celer
Journal:  Virus Genes       Date:  2006-12-01       Impact factor: 2.332

7.  Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV.

Authors:  Porntippa Nawagitgul; Perry A Harms; Igor Morozov; Brad J Thacker; Steven D Sorden; Chalermpol Lekcharoensuk; Prem S Paul
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

8.  Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISA.

Authors:  Pei-Ching Wu; Maw-Sheng Chien; Yu-Yao Tseng; Jiarong Lin; Wei-Li Lin; Cheng-Yao Yang; Chienjin Huang
Journal:  J Biotechnol       Date:  2007-10-02       Impact factor: 3.307

9.  Development of an ELISA based on the baculovirus-expressed capsid protein of porcine circovirus type 2 as antigen.

Authors:  Changming Liu; Takeshi Ihara; Tetsuo Nunoya; Susumu Ueda
Journal:  J Vet Med Sci       Date:  2004-03       Impact factor: 1.267

10.  An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome.

Authors:  Ph Blanchard; D Mahé; R Cariolet; C Truong; M Le Dimna; C Arnauld; N Rose; E Eveno; E Albina; F Madec; A Jestin
Journal:  Vet Microbiol       Date:  2003-07-17       Impact factor: 3.293

View more
  1 in total

1.  Expression and antigenicity characterization for truncated capsid protein of porcine circovirus type 2.

Authors:  Zhongzi Lou; Xuerui Li; Zhiyong Li; Xiangping Yin; Baoyu Li; Xi Lan; Bin Yang; Yun Zhang; Jixing Liu
Journal:  Can J Vet Res       Date:  2011-01       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.